Florida Facility

Resilience operates an 183,000-square-foot multi-purpose, multi-product biologics manufacturing facility in Alachua, FL, designated the Advanced Development and Manufacturing (ADM) facility. The ADM facility operates in compliance with CGMP.

The facility provides capabilities in:

  • Analytical Testing

  • Process Development and Scale-Up

  • CGMP Cell and Viral Banking

  • CGMP Manufacturing which can handle pathogens up to BioSafety Levels 3 (BSL-3)

  • Vaccine Products (bacteria, virus, and virus-like particles)
  • Monoclonal Antibodies from cell culture
  • Recombinant Proteins from other platforms (bacteria, insect, and yeast cells)
  • Cell and Gene Therapies (autologous and allogeneic)
  • CGMP Production of Master and Working Cell and Viral Banks
  • Concurrent manufacturing of multiple CGMP bulk biologics via four independent production rooms
  • Accommodation of Single-Use Technologies (SUT) to provide significant advantages in cost, operational flexibility, and reliability
  • Availability of traditional stainless steel equipment capable of Clean-In-Place (CIP) and Steam-In-Place (SIP) for fermentation and cell disruption
  • Process Development Laboratories to accommodate small and pilot scale development work including capability for BSL-3 agents
  • Quality Control (QC) in-process release and stability testing, including BSL-3 agents
  • Agile, flexible manufacturing based on single-use, skid mounted process equipment in both pilot plant and manufacturing core to facilitate the rapid changeover of process configurations for different platform technologies within production suites
  • The ability to accommodate up to four x 2,000 L bioreactors
  • Compliant commercial scale CGMP biologics manufacturing from BSL-1 through BSL-3